ADARFEP_10Y
Clinical Outcome After Antipsychotic Treatment Discontinuation in Functionally Recovered First-episode Non-affective Psychosis Individuals: a 10-year Follow-up
Sponsor study identifier
interventional
68
1 country
1
Study Start
September 2014
Actual (reported)Primary Completion
December 2017
Actual (reported)Study Completion
December 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
This open-label, non-randomized, prospective study will evaluate the risk of symptoms recurrence during the ten years after antipsychotic discontinuation in a sample of functionally recovered first-episode patients with schizophrenia spectrum disorder.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 2014
Actual (reported)March 14, 2017
Actual (reported)March 24, 2017
Actual (reported)December 2017
Actual (reported)December 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Relapse rate
The percentage of relapse/exacerbation in the two groups of patients, discontinuation and maintenance.
At 10 years
Change in general psychopathology measured by BPRS
At 10 years
Change in overall clinical status measured by CGI
At 10 years
Change in negative symptoms measured by SANS
At 10 years
Change in negative symptoms measured by SAPS
At 10 years
Time to relapse
At 10 years
Antipsychotic treatment discontinuation (DT)
Maintenance antipsychotic treatment (MT)
Withdrawal of antipsychotic medication to stabilized patients
Maintenance antipsychotic medication to stabilized patients
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
University Hospital Marques de Valdecilla
Santander, Cantabria, 39008, Spain
Benedicto Crespo-Facorro, Professor
University Hospital Marqués de Valdecilla, IDIVAL, Department of Psychiatry, School of Medicine, University of Cantabria, Santander, Spain. CIBERSAM Centro Investigación Biomédica en Red Salud Mental, Madrid, Spain
First Submitted
March 14, 2017
First Posted
March 24, 2017
Study Start
September 2014
Actual (reported)Primary Completion
December 2017
Actual (reported)Brain Image Markers Associated With Cognitive Training and Aerobic Exercise in Schizophrenia
Contact the study team to confirm eligibility.
Study Completion
December 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
January 14, 2020
Record last verified: 2020-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: